Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles

Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R: Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2: 751-760. 10.1038/nnano.2007.387

Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46: 6387-6392.

Bae YH, Park K: Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 2011, 153: 198-205. 10.1016/j.jconrel.2011.06.001

Jokerst JV, Lobovkina T, Zare RN, Gambhir SS: Nanoparticle PEGylation for imaging and therapy. Nanomedicine-UK 2011, 6: 715-728. 10.2217/nnm.11.19

Kamaly N, Xiao ZY, Valencia PM, Radovic-Moreno AF, Farokhzad OC: Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012, 41: 2971-3010. 10.1039/c2cs15344k

Drobek T, Spencer ND, Heuberger M: Compressing PEG brushes. Macromolecules 2005, 38: 5254-5259. 10.1021/ma0504217

Kenausis GL, Voros J, Elbert DL, Huang NP, Hofer R, Ruiz-Taylor L, Textor M, Hubbell JA, Spencer ND: Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: attachment mechanism and effects of polymer architecture on resistance to protein adsorption. J Phys Chem B 2000, 104: 3298-3309. 10.1021/jp993359m

Stolnik S, Illum L, Davis SS: Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 1995, 16: 195-214. 10.1016/0169-409X(95)00025-3

Storm G, Belliot SO, Daemen T, Lasic DD: Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 1995, 17: 31-48. 10.1016/0169-409X(95)00039-A

Ma XW, Zhao YL, Liang XJ: Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc Chem Res 2011, 44: 1114-1122. 10.1021/ar2000056

Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F: Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine-UK 2006, 2: 8-21. 10.1016/j.nano.2005.12.003

Nicolas J, Couvreur P: Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1: 111-127. 10.1002/wnan.15

Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P: Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003, 55: 519-548. 10.1016/S0169-409X(03)00041-3

Mørch Ý, Hansen R, Berg S, Åslund AKO, Glomm WR, Eggen S, Schmid R, Johnsen H, Kubowicz S, Snipstad S, Sulheim E, Hak S, Singh G, McDonagh BH, Blom H, Davies C de L, Stenstad PM: Nanoparticle-stabilized microbubbles for ultrasound-enhanced drug delivery and imaging. In review at Contrast Media Mol Imaging 2014.

Burke CW, Hsiang YH, Alexander E, Kilbanov AL, Price RJ: Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle. Small 2011, 7: 1227-1235. 10.1002/smll.201001934

Xu P, Gullotti E, Tong L, Highley CB, Errabelli DR, Hasan T, Cheng JX, Kohane DS, Yeo Y: Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm 2009, 6: 190-201. 10.1021/mp800137z

Panyam J, Labhasetwar V: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55: 329-347. 10.1016/S0169-409X(02)00228-4

Nam HY, Kwon SM, Chung H, Lee SY, Kwon SH, Jeon H, Kim Y, Park JH, Kim J, Her S, Oh YK, Kwon IC, Kim K, Jeong SY: Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release 2009, 135: 259-267. 10.1016/j.jconrel.2009.01.018

Hillaireau H, Couvreur P: Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66: 2873-2896. 10.1007/s00018-009-0053-z

Taurin S, Nehoff H, Greish K: Anticancer nanomedicine and tumor vascular permeability; where is the missing link? J Control Release 2012, 164: 265-275. 10.1016/j.jconrel.2012.07.013

Panyam J, Labhasetwar V: Targeting intracellular targets. Curr Drug Deliv 2004, 1: 235-247. 10.2174/1567201043334768

Iversen TG, Skotland T, Sandvig K: Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011, 6: 176-185. 10.1016/j.nantod.2011.02.003

Lin Q, Chen J, Ng KK, Cao W, Zhang Z, Zheng G: Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles. Pharm Res 2014, 31: 1438-1449. 10.1007/s11095-013-1046-z

Kumari A, Yadav SK, Yadav SC: Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010, 75: 1-18. 10.1016/j.colsurfb.2009.09.001

Torchilin VP: Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006, 8: 343-375. 10.1146/annurev.bioeng.8.061505.095735

Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V: Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002, 16: 1217-1226. 10.1096/fj.02-0088com

Partlow KC, Lanza GM, Wickline SA: Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. Biomaterials 2008, 29: 3367-3375. 10.1016/j.biomaterials.2008.04.030

Hofmann D, Messerschmidt C, Bannwarth MB, Landfester K, Mailander V: Drug delivery without nanoparticle uptake: delivery by a kiss-and-run mechanism on the cell membrane. Chem Commun 2014, 50: 1369-1371. 10.1039/c3cc48130a

Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA: Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent implications for rational therapy of restenosis. Circulation 2002, 106: 2842-2847. 10.1161/01.CIR.0000044020.27990.32

Haynes LC, Cho MJ: Mechanism of Nile Red transfer from O/W emulsions as carriers for passive-drug targeting to peritoneal-macrophages invitro. Int J Pharm 1988, 45: 169-177. 10.1016/0378-5173(88)90048-8

Greenspan P, Mayer EP, Fowler SD: Nile Red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 1985, 100: 965-973. 10.1083/jcb.100.3.965

Åslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P, Holtzman DM, Hof PR, Heppner FL, Gandy S, Jucker M, Aguzzi A, Hammarström P, Nilsson KPR: Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 2009, 4: 673-684. 10.1021/cb900112v

Bootz A, Vogel V, Schubert D, Kreuter J: Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 2004, 57: 369-375. 10.1016/S0939-6411(03)00193-0

Garaiova Z, Strand SP, Reitan NK, Lelu S, Størset SØ, Berg K, Malmo J, Folasire O, Bjørkøy A, Davies C de L: Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways. Int J Biol Macromol 2012, 51: 1043-1051. 10.1016/j.ijbiomac.2012.08.016

Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM: The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 2009, 30: 2790-2798. 10.1016/j.biomaterials.2009.01.057

Dausend J, Musyanovych A, Dass M, Walther P, Schrezenmeier H, Landfester K, Mailander V: Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol Biosci 2008, 8: 1135-1143. 10.1002/mabi.200800123

Brambilla D, Nicolas J, Le Droumaguet B, Andrieux K, Marsaud V, Couraud PO, Couvreur P: Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging. Chem Commun 2010, 46: 2602-2604. 10.1039/b924028d

Diaz G, Melis M, Batetta B, Angius F, Falchi AM: Hydrophobic characterization of intracellular lipids in situ by Nile Red red/yellow emission ratio. Micron 2008, 39: 819-824. 10.1016/j.micron.2008.01.001

Brown WJ, Sullivan TR, Greenspan P: Nile Red staining of lysosomal phospholipid inclusions. Histochemistry 1992, 97: 349-354. 10.1007/BF00270037

Diaz G, Melis M, Musinu A, Piludu M, Piras M, Falchi AM: Localization of MTT formazan in lipid droplets. An alternative hypothesis about the nature of formazan granules and aggregates. Eur J Histochem 2007, 51: 213-218.

Greenspan P, Fowler SD: Spectrofluorometric studies of the lipid probe, Nile Red. J Lipid Res 1985, 26: 781-789.

Klymchenko AS, Roger E, Anton N, Anton H, Shulov I, Vermot J, Mely Y, Vandamme TF: Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets. Rsc Adv 2012, 2: 11876-11886. 10.1039/c2ra21544f

Mørch ÝA, Eggen S, Åslund A, Sulheim E, Snipstad S, Borgos SEF, Glomm W, Singh G, Davies CDL, Stenstad PM, Schmid R: Optimization and characterization of PACA nanoparticles for drug delivery and imaging. 41st Annual Meeting of the Controlled Release Society 2014.

Tenuta T, Monopoli MP, Kim J, Salvati A, Dawson KA, Sandin P, Lynch I: Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One 2011, 6: e25556. 10.1371/journal.pone.0025556

Petersen S, Fahr A, Bunjes H: Flow cytometry as a new approach to investigate drug transfer between lipid particles. Mol Pharm 2010, 7: 350-363. 10.1021/mp900130s

de Verdiere AC, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P: Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother Pharmacol 1994, 33: 504-508. 10.1007/BF00686509

Salvati A, Aberg C, dos Santos T, Varela J, Pinto P, Lynch I, Dawson KA: Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine-UK 2011, 7: 818-826. 10.1016/j.nano.2011.03.005

Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Zhang HY, Wickline SA, Lanza GM: Endothelial alpha(v)beta(3) integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26: 2103-2109. 10.1161/01.ATV.0000235724.11299.76